Role of peroxisome proliferator-activated receptor-α in hepatobiliary injury induced by ammonium perfluorooctanoate in mouse liver

Industrial Health

Volumn 48, Issue 1, 2010, Pages 96-107

  Minata, Mutsuko ^a   Harada, Kouji H ^a   Kärrman, Anna ^b   Hitomi, Toshiaki ^a   Hirosawa, Michi ^a   Murata, Mariko ^c   Gonzalez, Frank J ^d   Koizumi, Akio ^a  

^a KYOTO UNIVERSITY   (Japan)

^b ÖREBRO UNIVERSITY   (Sweden)

^c MIE UNIVERSITY   (Japan)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Bile acid transporter; Hepatobiliary injury; Histopathology; Perfluorooctanoic acid; Peroxisome proliferator activated receptor

Indexed keywords

FLUOROCARBON; HEXADECAFLUORO NONANOIC ACID; HEXADECAFLUORO-NONANOIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA;

ANIMAL; ARTICLE; BILE DUCT; DOSE RESPONSE; DRUG EFFECT; INJURY; MOLECULAR GENETICS; MOUSE; MOUSE MUTANT; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PATHOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TOXIC HEPATITIS;

ANIMALS; BASE SEQUENCE; BILE DUCTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG-INDUCED LIVER INJURY; FLUOROCARBONS; MICE; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; OXIDATIVE STRESS; PPAR ALPHA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

MUS; RODENTIA;

EID: 77249135053     PISSN: 00198366     EISSN: None     Source Type: Journal    
DOI: 10.2486/indhealth.48.96     Document Type: Article

References (34)

1. Kissa E (2001) Fluorinated surfactants and repellents, 2nd Ed., Marcel Dekker, New York.
2. Lau C, Anitole K, Hodes C, Lai D, Pfahles-Hutchens A, Seed J (2007) Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol Sci 99, 366-394
3. Harada K, Koizumi A (2009) Environmental and biological monitoring of persistent fluorinated compounds in Japan and their toxicities. Environmental Health and Preventive Medicine 14, 7-19.
4. Vanden Heuvel JP, Thompson JT, Frame SR, Gillies PJ (2006) Differential activation of nuclear receptors by perfluorinated fatty acid analogs and natural fatty acids: a comparison of human, mouse, and rat peroxisome proliferator-activated receptor-alpha, -beta, and -gamma, liver X receptor-beta, and retinoid X receptor-alpha. Toxicol Sci 92, 476-489
5. Kennedy GL, Jr., Butenhoff JL, Olsen GW, O'Connor JC, Seacat AM, Perkins RG, Biegel LB, Murphy SR, Farrar DG (2004) The toxicology of perfluorooctanoate. Crit Rev Toxicol 34, 351-384
6. Abdellatif AG, Preat V, Vamecq J, Nilsson R, Roberfroid M (1990) Peroxisome proliferation and modulation of rat liver carcinogenesis by 2,4-dichlorophe-noxyacetic acid, 2,4,5-trichlorophenoxyacetic acid, perfluorooctanoic acid and nafenopin. Carcinogenesis 11, 1899-1902
7. Rosen MB, Abbott BD, Wolf DC, Corton JC, Wood CR, Schmid JE, Das KP, Zehr RD, Blair ET, Lau C (2008) Gene profiling in the livers of wild-type and PPARalpha-null mice exposed to perfluorooctanoic acid. Toxicol Pathol 36, 592-607.
8. Wolf DC, Moore T, Abbott BD, Rosen MB, Das KP, Zehr RD, Lindstrom AB, Strynar MJ, Lau C (2008) Comparative hepatic effects of perfluorooctanoic acid and WY 14,643 in PPAR-alpha knockout and wild-type mice. Toxicol Pathol 36, 632-639
9. Hays T, Rusyn I, Burns AM, Kennett MJ, Ward JM, Gonzalez FJ, Peters JM (2005) Role of peroxisome proliferator-activated receptor-alpha (PPARalpha) in bezafibrate-induced hepatocarcinogenesis and cholestasis. Carcinogenesis 26, 219-227
10. Velayudham LS, Farrell GC (2003) Drug-induced cholestasis. Expert Opin Drug Saf 2, 287-304.
11. Bhat HK, Kanz MF, Campbell GA, Ansari GA (1991) Ninety day toxicity study of chloroacetic acids in rats. Fundam Appl Toxicol 17, 240-253
12. Luft JH (1961) Improvements in epoxy resin embedding methods. J Biophys Biochem Cytol 9, 409-414
13. Reynolds ES (1963) The use of lead citrate at high pH as an electron-opaque stain in electron microscopy. J Cell Biol 17, 208-212
14. Ylinen M, Hanhijärvi H, Peura P, Rämö O (1985) Quantitative gas chromatographic determination of perfluorooctanoic acid as the benzyl ester in plasma and urine. Arch Environ Contam Toxicol 14, 713-717
15. Iwai S, Murai T, Makino S, Min W, Morimura K, Mori S, Hagihara A, Seki S, Fukushima S (2007) High sensitivity of fatty liver Shionogi (FLS) mice to diethylnitrosamine hepatocarcinogenesis: comparison to C3H and C57 mice. Cancer Lett 246, 115-121
16. Murata M, Kurimoto S, Kawanishi S (2006) Tyrosine-dependent oxidative DNA damage induced by carcinogenic tetranitromethane. Chem Res Toxicol 19, 1379-1385
17. Hirosawa M, Minata M, Harada KH, Hitomi T, Krust A, Koizumi A (2008) Ablation of estrogen receptor alpha (ERalpha) prevents upregulation of POMC by leptin and insulin. Biochem Biophys Res Commun 371, 320-323
18. Wagner M, Halilbasic E, Marschall HU, Zollner G, Fickert P, Langner C, Zatloukal K, Denk H, Trauner M (2005) CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice. Hepatology 42, 420-430
19. Yang Q, Abedi-Valugerdi M, Xie Y, Zhao XY, Moller G, Nelson BD, DePierre JW (2002) Potent suppression of the adaptive immune response in mice upon dietary exposure to the potent peroxisome proliferator, perfluorooctanoic acid. Int Immunopharmacol 2, 389-397
20. Fickert P, Fuchsbichler A, Wagner M, Zollner G, Kaser A, Tilg H, Krause R, Lammert F, Langner C, Zatloukal K, Marschall HU, Denk H, Trauner M (2004) Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice. Gastroenterology 127, 261-274
21. Alrefai WA, Gill RK (2007) Bile acid transporters: structure, function, regulation and pathophysiological implications. Pharm Res 24, 1803-1823
22. Trauner M, Boyer JL (2003) Bile salt transporters: molecular characterization, function, and regulation. Physiol Rev 83, 633-671
23. Zollner G, Fickert P, Zenz R, Fuchsbichler A, Stumptner C, Kenner L, Ferenci P, Stauber RE, Krejs GJ, Denk H, Zatloukal K, Trauner M (2001) Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases. Hepatology 33, 633-646 (Pubitemid 32185226)
24. Trauner M, Arrese M, Soroka CJ, Ananthanarayanan M, Koeppel TA, Schlosser SF, Suchy FJ, Keppler D, Boyer JL (1997) The rat canalicular conjugate export pump (Mrp2) is down-regulated in intrahepatic and obstructive cholestasis. Gastroenterology 113, 255-264 (Pubitemid 27281782)
25. Cheng X, Klaassen CD (2008) Critical role of PPAR-alpha in perfluorooctanoic acid- and perfluorodecanoic acid-induced downregulation of Oatp uptake transporters in mouse livers. Toxicol Sci 106, 37-45.
26. Maher JM, Aleksunes LM, Dieter MZ, Tanaka Y, Peters JM, Manautou JE, Klaassen CD (2008) Nrf2- and PPAR alpha-mediated regulation of hepatic Mrp transporters after exposure to perfluorooctanoic acid and perfluorodecanoic acid. Toxicol Sci 106, 319-328
27. Schrenk D, Gant TW, Preisegger KH, Silverman JA, Marino PA, Thorgeirsson SS (1993) Induction of multidrug resistance gene expression during cholestasis in rats and nonhuman primates. Hepatology 17, 854-860 (Pubitemid 23150095)
28. Rosen MB, Lee JS, Ren H, Vallanat B, Liu J, Waalkes MP, Abbott BD, Lau C, Corton JC (2008) Toxicogenomic dissection of the perfluorooctanoic acid transcript profile in mouse liver: evidence for the involvement of nuclear receptors PPAR alpha and CAR. Toxicol Sci 103, 46-56.
29. Hartmann G, Cheung AK, Piquette-Miller M (2002) Inflammatory cytokines, but not bile acids, regulate expression of murine hepatic anion transporters in endotoxemia. J Pharmacol Exp Ther 303, 273-281 (Pubitemid 35056478)
30. Green RM, Hoda F, Ward KL (2000) Molecular cloning and characterization of the murine bile salt export pump. Gene 241, 117-123
31. Lu TT, Makishima M, Repa JJ, Schoonjans K, Kerr TA, Auwerx J, Mangelsdorf DJ (2000) Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol Cell 6, 507-515
32. Goodwin B, Jones SA, Price RR, Watson MA, McKee DD, Moore LB, Galardi C, Wilson JG, Lewis MC, Roth ME, Maloney PR, Willson TM, Kliewer SA (2000) A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol Cell 6, 517-526
33. Kok T, Bloks VW, Wolters H, Havinga R, Jansen PL, Staels B, Kuipers F (2003) Peroxisome proliferator-activated receptor alpha (PPARalpha)-mediated regulation of multidrug resistance 2 (Mdr2) expression and function in mice. Biochem J 369, 539-547 (Pubitemid 36246237)
34. Gonzalez FJ, Shah YM (2008) PPARalpha: mechanism of species differences and hepatocarcinogenesis of peroxisome proliferators. Toxicology 246, 2-8.